Sciclone Pharmaceuticals Is A Global Biopharmaceutical Company Focused On Developing And Commercializing Therapies For Oncologyinfectious Diseasesand Immunologyfounded In 1990 In Californiathe Company Has A Significant Presence In China And Other International Marketsit Was Listed On The Hong Kong Stock Exchange In 2021Following A Restructuring After Its Delisting From Nasdaq In 2017 The Company S Flagship Productzadaxinis An Immunomodulatory Drug Used For Hepatitis B And Cas Well As An Adjunct Therapy For Certain Cancerssciclone Also Has A Diverse Oncology Portfolio And Offers Antiviral And Antibacterial Treatments Through Its Infectious Disease Solutionsthe Company Provides Comprehensive Market Access And Commercialization Servicesincluding Regulatory Affairs And Pharmacovigilancewith A Dedicated Leadership Team And A Focus On R&Dsciclone Operates In Over 30 Countriespartnering With Local Healthcare Providers And Regulatory Bodies To Enhance Patient Care
